| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | -0.27 | 7e-09 |
| mRNA | AS605240 | GDSC1000 | pan-cancer | AAC | -0.23 | 5e-08 |
| mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | -0.21 | 2e-07 |
| mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | 0.23 | 7e-07 |
| mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | -0.2 | 2e-06 |
| mRNA | CH5424802 | GDSC1000 | pan-cancer | AAC | -0.2 | 2e-06 |
| mRNA | PD318088 | CTRPv2 | pan-cancer | AAC | -0.2 | 3e-06 |
| mRNA | selumetinib:navitoclax (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.2 | 5e-06 |
| mRNA | prima-1 | CTRPv2 | pan-cancer | AAC | 0.17 | 7e-06 |
| mRNA | BRD-K03536150 | CTRPv2 | pan-cancer | AAC | 0.2 | 8e-06 |